Jeronselvain to Host "2026 PDRN Symposium," Presenting a Vision for Next-Generation Regenerative Medicine

Jeronselvain, a company specializing in the production of prescription drugs, announced on January 14 that it will host the "2026 2nd PDRN Symposium."

This symposium is scheduled to take place on February 22 at the 12th floor of the Daeyang AI Center at Sejong University in Seoul. It is expected to serve as a venue to explore the latest research trends and real clinical outcomes related to polydeoxyribonucleotide (PDRN) in one place.

Last February, Jeronselvain drew significant interest from private practitioners in its PDRN injectable "Selvain Injection" at the "2025 PDRN Symposium," which attracted over 500 clinicians.

This year's symposium will provide an in-depth look at a wide range of clinical applications and the latest research findings on PDRN, spanning dental clinical practice, regenerative medicine, bone immunology, aesthetics, and anti-aging.

In particular, the program will be structured around practical content that can be immediately applied in clinical settings, with hands-on sessions designed for private practitioners and clinicians to utilize right away, which is expected to garner strong interest.

The symposium will feature lectures by professors and directors from leading domestic medical institutions. It will begin with a presentation by Professor Park Wonseo of Yonsei University Dental Hospital titled "PDRN: A Novel Approach, pilot study." This will be followed by lectures from Kim Hyungjun, Director of OFP Oral Medicine Dental Clinic, on "Pathophysiology of Temporomandibular Joint Disorders and PDRN Injection Therapy," and Yoon Jongil, Vice President of the PDRN Immunoregenerative Dental Research Society (Director of Yeon Dental Clinic), on "Understanding PDRN, Dental Clinical Practice, and Bone Immunology."

In the afternoon session, Kim Yongjin, Director of Yesmir Dental Clinic, will present "PDRN, The Second Story," Koo Jeongkwi, Professor at Bundang Seoul National University Hospital, will discuss "Integrating PDRN into Regenerative Dentistry: New Clinical Observations," Koo Kitae, Professor at Seoul National University Dental Hospital, will speak on "PDRN and Peri-implantitis," Kwon Yongdae, Professor at Kyung Hee University Dental Hospital, will address "Ridge Augmentation Founded Upon Faster Soft Tissue Healing," Jang Hyundong, Director of Hyun Hospital (President of the Korean Society of Manual Medicine), will lecture on "Practical Use of Selvain Injection in Medicine: Applications in Infection, Aesthetics, Hair Loss, and Anti-aging," and Kim Youngjun, Professor at Youngsan University, will present "Practical Strategies for PDRN to Transform Private Practitioners' Revenue Models: Designing Regenerative Revenue Streams for Immediate Application in Dental Clinics."

Finally, Jeronselvain CEO Kim Deokgyu will deliver a lecture on "How to Easily Apply Selvain Injection in the Anti-aging (Skin Wrinkle) Market to Achieve Results."

Kim Deokgyu, CEO of Jeronselvain, stated, "PDRN has tremendous potential for clinical expansion across dentistry and regenerative medicine. This symposium will go beyond theoretical introductions to share real clinical results and practical know-how, providing tangible benefits to medical professionals."